|
| DOE-STD-1136-2004
Guide of Good Practices for Occupational Radiological Protection in Uranium Facilities
Table 5 -7. Minimum Suggested Frequencies for Routine Bioassay for Uranium(a)
FREQUENCY
SOLUBILITY
SITUATION
CLASS
URINE
FECAL
IN VIVO
Radiological
D
Monthly
(b)
(b)
W
Quarterly
Annually
Special Y
Quarterly
Annually
Y
(b)
Annually
Chemical Toxicity
Annually (c)
D and W
Monthly
(a) From ICRP Publication , 1995.
(b) The method of analysis not usually used.
(c) For Class W.
5.4.2 Frequency Based on Potential Risk of Intake
Although uranium workers are not generally considered to be at high risk of incurring intakes that
might result in CEDEs of 0.1 rem or more, any uranium worker can be considered to have the potential for
such an intake (see Section 5.3.2). However, having the potential for intake does not mean that they are
likely to incur an intake.
Workers who have the highest potential risk for an intake are those most closely working with uranium
or uranium-contaminated material. Typically, these workers are glove-box workers, maintenance workers,
and operational radiological control surveillance staff. These workers should be on a routine uranium
bioassay program, including urinalysis and in vivo measurements. Such programs are relatively insensitive
compared to the 0.1 rem CEDE monitoring threshold and are a safety net intended to catch intakes of
significance relative to regulatory limits, rather than substantially lower administrative levels. Selection of
bioassay frequency depends on the facility experience with potential intakes, the perceived likelihood of
intake, and the MDD of a program. Annual urinalyses and in vivo chest counts are fairly typical. More
frequent (e.g., semi-annual or quarterly) measurements may permit more timely review of workplace
indicators in the event that an abnormal bioassay result is obtained, but do not necessarily mean a more
sensitive program.
5.4.3 Special Bioassay as Supplements to Routine Bioassay Programs
Special bioassay programs for workers with known or suspected acute inhalation intakes of uranium or
other alpha-emitting radionuclides should include both urine and fecal sampling. Special bioassay
measurements should be initiated for each employee in a contaminated work area when surface
contamination is detected by routine surveillance if it is possible that the contamination resulted in a CEDE
of 0.1 rem or greater. Excreta samples should not be collected where they may be contaminated by external
sources of uranium. Ideally, total urine and feces should be collected for about a week
5-16
|
Privacy Statement - Press Release - Copyright Information. - Contact Us |